Zevra Therapeutics, Inc. (ZVRA) Gross margin 2019–2023
Zevra Therapeutics, Inc. (ZVRA) gross margin by fiscal year — reported gross profit divided by reported revenue.
89.3%FY2023 · since FY2019: 22.1% → 89.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 89.3% | -8.5 pp |
| FY2022 | 97.8% | +5.0 pp |
| FY2021 | 92.8% | — |
| FY2019 | 22.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice